Intervention not reported
Patient‐reported disease‐specific symptom scores Symptom score with scale of 0 to 3 (0 = no symptoms, 3 = severe symptoms)
The intervention showed no clear difference in patient‐reported disease‐specific symptom scores Symptom score with… (low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life scores, measured by SF‐36 (range 0 to 100)
The intervention showed no clear difference in health‐related quality of life scores, measured by SF‐36 (range 0 to… (low certainty).
1 finding from 1 review
Intervention not reported
Endoscopic appearances 0 to 3 (0 = no polyps, 3 = severe polyposis)
The intervention showed no clear difference in endoscopic appearances 0 to 3 (0 = no polyps, 3 = severe polyposis) (low certainty).
1 finding from 1 review
Intervention not reported
Complications
1 finding from 1 review
Intervention not reported
Objective physiological measures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Olfactory tests
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality or liver‐related morbidity · patients with chronic hepatitis C
It is very uncertain whether the intervention changes all‐cause mortality or liver‐related morbidity (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with chronic hepatitis C
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Failure of end of treatment virological response Absence of clearance of HCV RNA from the blood at end of treatment · patients with chronic hepatitis C
The intervention showed no clear difference in failure of end of treatment virological response Absence of… (moderate certainty).
1 finding from 1 review
Intervention not reported
Failure of sustained virological response Absence of clearance of HCV RNA from the blood 6 months after treatment · patients with chronic hepatitis C
The intervention showed no clear difference in failure of sustained virological response Absence of clearance of… (moderate certainty).
1 finding from 1 review
Intervention not reported
Quality of life Different QoL scales · patients with chronic hepatitis C
1 finding from 1 review
Intervention not reported
Failure of normalisation of ALT at end of treatment · patients with chronic hepatitis C
The intervention may leads to lower failure of normalisation of ALT at end of treatment (low certainty).
1 finding from 1 review
Intervention not reported
Failure of normalisation of ALT at end of · patients with chronic hepatitis C
The intervention showed no clear difference in failure of normalisation of ALT at end of (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality or liver‐related morbidity · patients with chronic hepatitis C.
It is very uncertain whether the intervention changes all‐cause mortality or liver‐related morbidity (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with chronic hepatitis C.
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Failure of sustained virological response Absence of clearance of HCV RNA from the blood 6 months after treatment · patients with chronic hepatitis C.
The intervention may leads to higher failure of sustained virological response Absence of clearance of… (low certainty).
1 finding from 1 review
Intervention not reported
Failure of end of treatment virological response Absence of clearance of HCV RNA from the blood at end of treatment · patients with chronic hepatitis C.
The intervention may leads to higher failure of end of treatment virological response Absence of… (low certainty).
1 finding from 1 review
Intervention not reported
Failure of normalisation of ALT at end of treatment · patients with chronic hepatitis C.
It is very uncertain whether the intervention changes failure of normalisation of ALT at end of treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Failure of normalisation of ALT at end of · patients with chronic hepatitis C.
It is very uncertain whether the intervention changes failure of normalisation of ALT at end of (very low certainty).
1 finding from 1 review
Proportion of patients with >50% maximum pain relief (TOTPAR) over 2 hours · Patients with pain after surgical removal of lower wisdom teeth (third molars) requiring bone removal or with baseline moderate to severe…
Combined paracetamol plus ibuprofen in a single tablet (e.g.… showed no clear difference in proportion of patients with >50% maximum pain relief (TOTPAR) over 2… compared with single drugs given separately (paracetamol 1000 mg or ibuprofen 400… (moderate certainty).
1 finding from 1 review